Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients

被引：0

作者：

Palumbo, Antonio ^{[1
]}

Bringhen, Sara ^{[1
]}

Rossi, Davide ^{[2
]}

Ria, Roberto ^{[2
]}

Offidani, Massimo ^{[2
]}

Patriarca, Francesca ^{[2
]}

Nozzoli, Chiara ^{[2
]}

Levi, Anna ^{[2
]}

Guglielmelli, Tommasina ^{[2
]}

Benevolo, Giulia ^{[2
]}

Callea, Vincenzo ^{[2
]}

Olivero, Barbara ^{[2
]}

Morabito, Fortunato ^{[2
]}

Grasso, Mariella ^{[2
]}

Marasca, Roberto ^{[2
]}

Rizzo, Manuela ^{[2
]}

Falcone, Antonietta Pia ^{[2
]}

Gottardi, Daniela ^{[3
]}

Montefusco, Vittorio ^{[2
]}

Musolino, Caterina ^{[2
]}

Zambello, Renato ^{[2
]}

Cangialosi, Clotilde ^{[2
]}

Pietrantuono, Giuseppe ^{[2
]}

Magarotto, Valeria ^{[1
]}

Petrucci, Maria Teresa ^{[2
]}

Musto, Pellegrino ^{[2
]}

Ciccone, Giovannino ^{[4
,5
]}

Di Raimondo, Francesco ^{[2
]}

Gaidano, Gianluca ^{[2
]}

Boccadoro, Mario ^{[1
]}

机构：

[1] Univ Turin, Div Hematol, AOU San Giovanni Battista, Turin, Italy

[2] GIMEMA, Italian Multiple Myeloma Network, Turin, Italy

[3] ASO Mauriziano, SCDU Ematol & Terapie Cellulari, Turin, Italy

[4] Univ Turin, Canc Epidemiol Unit, Turin, Italy

[5] AOU San Giovanni Battista, CPO Piemonte, Turin, Italy

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：58 / 58

页数：1

共 50 条

[1] Bortezomib, melphalan, prednisone, and thalidomide (VMPT) followed by maintenance with bortezomib and thalidomide (VT) for initial treatment of elderly multiple myeloma patients
Boccadoro, M.
Bringhen, S.
Gaidano, G.
Ria, R.
Offidani, M.
Patriarca, F.
Nozzoli, C.
Musto, P.
Petrucci, M.
Palumbo, A. P.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[2] Bortezomib, Melphalan, Prednisone and Thalidomide Followed by Maintenance with Bortezomib and Thalidomide (VMPT-VT) for Initial Treatment of Elderly Multiple Myeloma Patients: Updated Follow-up and Impact of Prognostic Factors
Palumbo, Antonio
Bringhen, Sara
Cavalli, Maide
Ria, Roberto
Offidani, Massimo
Patriarca, Francesca
Nozzoli, Chiara
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Zambello, Renato
Pietrantuono, Giuseppe
De Rosa, Luca
Liberati, Anna Marina
Crippa, Claudia
Perrone, Giulia
Ciambelli, Fabrizio
Carella, Angelo Michele
Palmieri, Salvatore
Gilestro, Milena
Magarotto, Valeria
Petrucci, Maria Teresa
Musto, Pellegrino
Gaidano, Gianluca
Boccadoro, Mario
[J]. BLOOD, 2010, 116 (21) : 272 - 273
[3] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
Mateos, Maria-Victoria
Oriol, Albert
Martinez-Lopez, Joaquin
Gutierrez, Norma
Teruel, Ana-Isabel
de Paz, Raquel
Garcia-Larana, Jose
Bengoechea, Enrique
Martin, Alejandro
Diaz Mediavilla, Joaquin
Palomera, Luis
de Arriba, Felipe
Gonzalez, Yolanda
Hernandez, Jose-Mariano
Sureda, Ana
Bello, Jose-Luis
Bargay, Joan
Penalver, Francisco-Javier
Ribera, Jose-Maria
Martin-Mateos, Maria-Luisa
Garcia-Sanz, Ramon
Cibeira, Maria-Teresa
Martin Ramos, Maria-Luisa
Vidriales, Maria-Belen
Paiva, Bruno
Montalban, Maria-Angeles
Lahuerta, Juan-Jose
Blade, Joan
San Miguel, Jesus-Fernando
[J]. LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
[4] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial
Palumbo, Antonio
Bringhen, Sara
Rossi, Davide
Cavalli, Maide
Larocca, Alessandra
Ria, Roberto
Offidani, Massimo
Patriarca, Francesca
Nozzoli, Chiara
Guglielmelli, Tommasina
Benevolo, Giulia
Callea, Vincenzo
Baldini, Luca
Morabito, Fortunato
Grasso, Mariella
Leonardi, Giovanna
Rizzo, Manuela
Falcone, Antonietta Pia
Gottardi, Daniela
Montefusco, Vittorio
Musto, Pellegrino
Petrucci, Maria Teresa
Ciccone, Giovannino
Boccadoro, Mario
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5101 - 5109
[5] BORTEZOMIB-MELPHALAN-PREDNISONE-THALIDOMIDE FOLLOWED BY BORTEZOMIB-THALIDOMIDE MAINTENANCE FOR INITIAL THERAPY OF MULTIPLE MYELOMA: A PROSPECTIVE RANDOMIZED TRIAL
Palumbo, A.
Bringhen, S.
Rossi, D.
Ria, R.
Offidani, M.
Musto, P.
Petrucci, M. T.
Omede, P.
Di Raimondo, F.
Boccadoro, M.
[J]. ANNALS OF ONCOLOGY, 2010, 21 : 350 - 350
[6] Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients
Palumbo, Antonio
Bringhen, Sara
Rossi, Dmide
Cavalli, Maide
Ria, Roberto
Gentilini, Silvia
Patriarca, Francesca
Nozzoli, Chiara
Levi, Anna
Guglielmelli, Tommasina
Benevolo, Giulia
Vincelli, Donatella
Baldini, Luca
Morabito, Fortunato
Grasso, Mariella
Marasca, Roberto
Rizzo, Manuela
Pautasso, Chiara
Falcone, Antonietta Pia
Gottardi, Daniela
Montefusco, Vittorio
Musolino, Caterina
Cangialosi, Clotilde
Mansueto, Giovanna
Liberati, Anna Marina
Magarotto, Valeria
Omede, Paola
Musto, Pellegrino
Petrucci, Maria Teresa
Boccadoro, Mario
[J]. BLOOD, 2012, 120 (21)
[7] Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment
Morabito, Fortunato
Gentile, Massimo
Mazzone, Carla
Rossi, Davide
Di Raimondo, Francesco
Bringhen, Sara
Ria, Roberto
Offidani, Massimo
Patriarca, Francesca
Nozzoli, Chiara
Petrucci, Maria Teresa
Benevolo, Giulia
Vincelli, Iolanda
Guglielmelli, Tommasina
Grasso, Mariella
Marasca, Roberto
Baldini, Luca
Montefusco, Vittorio
Musto, Pellegrino
Cascavilla, Nicola
Majolino, Ignazio
Musolino, Caterina
Cavo, Michele
Boccadoro, Mario
Palumbo, Antonio
[J]. BLOOD, 2011, 118 (22) : 5759 - 5766
[8] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival
Palumbo, Antonio
Bringhen, Sara
Larocca, Alessandra
Rossi, Davide
Di Raimondo, Francesco
Magarotto, Valeria
Patriarca, Francesca
Levi, Anna
Benevolo, Giulia
Vincelli, Iolanda Donatella
Grasso, Mariella
Franceschini, Luca
Gottardi, Daniela
Zambello, Renato
Montefusco, Vittorio
Falcone, Antonietta Pia
Omede, Paola
Marasca, Roberto
Morabito, Fortunato
Mina, Roberto
Guglielmelli, Tommasina
Nozzoli, Chiara
Passera, Roberto
Gaidano, Gianluca
Offidani, Massimo
Ria, Roberto
Petrucci, Maria Teresa
Musto, Pellegrino
Boccadoro, Mario
Cavo, Michele
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (07) : 634 - +
[9] Prognostic factors in advanced multiple myeloma patients treated with the association of bortezomib, melphalan, prednisone and thalidomide (VMPT)
Palumbo, A.
Gay, F.
Ambrosini, M. T.
Benevolo, G.
Pregno, F.
Pescosta, N.
Callea, V
Cangialosi, C.
Caravita, T.
Morabito, F.
Musto, P.
Larocca, A.
Caltagirone, S.
Avonto, I
Cavallo, F.
Boccadoro, M.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 140 - 140
[10] Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
Palumbo, Antonio
Ambrosini, Maria Teresa
Benevolo, Giulia
Pregno, Patrizia
Pescosta, Norbert
Callea, Vincenzo
Cangialosi, Clotilde
Caravita, Tommaso
Morabito, Fortunato
Musto, Pellegrino
Bringhen, Sara
Falco, Patrizia
Avonto, Ilaria
Cavallo, Federica
Boccadoro, Mario
[J]. BLOOD, 2007, 109 (07) : 2767 - 2772

← 1 2 3 4 5 →